Decitabine in the treatment of acute myeloid leukemia in elderly patients

The majority of patients with acute myeloid leukemia (AML) are elderly and have a poor prognosis despite induction therapy. Decitabine, a DNA-hypomethylating agent that induces differentiation and apoptosis of leukemic cells, is a well-tolerated alternative to aggressive chemotherapy. It is currentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Priya, Cashen, Amanda F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917925/
https://www.ncbi.nlm.nih.gov/pubmed/24520204
http://dx.doi.org/10.2147/CMAR.S40600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917925/
https://www.ncbi.nlm.nih.gov/pubmed/24520204
http://dx.doi.org/10.2147/CMAR.S40600

Ejemplares similares